Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Canevari

Showing results (101-110 of 131) with videos related to

Pageof 14
Sort By:
International Journal of Cancer|December 2, 1993
Targeting of T lymphocytes against EGF-receptor+ tumor cells by bispecific monoclonal antibodies: requirement of CD3 molecule cross-linking for T-cell activationS Ferrini, A Cambiaggi, S Sforzini, et al.
International Journal of Cancer|May 8, 1992
Glycolipids carrying Le(y) are preferentially expressed on small-cell lung cancer cells as detected by the monoclonal antibody MLuC1F Leoni, M I Colnaghi, S Canevari, et al.
International Journal of Cancer|March 15, 1987
Characterization of human ovarian carcinoma-associated antigens defined by novel monoclonal antibodies with tumor-restricted specificityS Miotti, S Canevari, S Ménard, et al.
International Journal of Immunopharmacology|October 1, 1995
Preclinical evaluation of the ribosome-inactivating proteins PAP-1, PAP-S and RTA in miceF Benigni, S Canevari, M Gadina, et al.
Cancer Gene Therapy|July 27, 1999
DNA vaccination against the ovarian carcinoma-associated antigen folate receptor alpha (FRalpha) induces cytotoxic T lymphocyte and antibody responses in miceF Neglia, A M Orengo, M Cilli, et al.
The International Journal of Biological Markers|October 1, 1989
Detection of Lewis(a) antigen in sera of ovarian carcinoma patients by MOv2-MOv8 double-determinant radioimmunoassayL Mantovani, V Azzini, S Canevari, et al.
Cancer Research|September 29, 1998
Targeting of interleukin 2 to human ovarian carcinoma by fusion with a single-chain Fv of antifolate receptor antibodyC Melani, M Figini, D Nicosia, et al.
British Journal of Cancer|March 1, 1992
Study of the biological and prognostic significance of the antigen CaMBr8 on breast carcinomaP Facheris, F Perrone, S Ménard, et al.
Cancer Immunology, Immunotherapy : CII|July 1, 1997
Efficiency of T cell triggering by anti-CD3 monoclonal antibodies (mAb) with potential usefulness in bispecific mAb generationN Jacobs, A Mazzoni, D Mezzanzanica, et al.
Cancer Research|October 10, 1998
Selective localization of matrix metalloproteinase 9, beta1 integrins, and human lymphocyte antigen class I molecules on membrane vesicles shed by 8701-BC breast carcinoma cellsV Dolo, A Ginestra, D Cassarà, et al.
Pageof 14

Showing results (101-110 of 131) with videos related to

Sort By:
Pageof 14
International Journal of Cancer|December 2, 1993
Targeting of T lymphocytes against EGF-receptor+ tumor cells by bispecific monoclonal antibodies: requirement of CD3 molecule cross-linking for T-cell activationS Ferrini, A Cambiaggi, S Sforzini, et al.
International Journal of Cancer|May 8, 1992
Glycolipids carrying Le(y) are preferentially expressed on small-cell lung cancer cells as detected by the monoclonal antibody MLuC1F Leoni, M I Colnaghi, S Canevari, et al.
International Journal of Cancer|March 15, 1987
Characterization of human ovarian carcinoma-associated antigens defined by novel monoclonal antibodies with tumor-restricted specificityS Miotti, S Canevari, S Ménard, et al.
International Journal of Immunopharmacology|October 1, 1995
Preclinical evaluation of the ribosome-inactivating proteins PAP-1, PAP-S and RTA in miceF Benigni, S Canevari, M Gadina, et al.
Cancer Gene Therapy|July 27, 1999
DNA vaccination against the ovarian carcinoma-associated antigen folate receptor alpha (FRalpha) induces cytotoxic T lymphocyte and antibody responses in miceF Neglia, A M Orengo, M Cilli, et al.
The International Journal of Biological Markers|October 1, 1989
Detection of Lewis(a) antigen in sera of ovarian carcinoma patients by MOv2-MOv8 double-determinant radioimmunoassayL Mantovani, V Azzini, S Canevari, et al.
Cancer Research|September 29, 1998
Targeting of interleukin 2 to human ovarian carcinoma by fusion with a single-chain Fv of antifolate receptor antibodyC Melani, M Figini, D Nicosia, et al.
British Journal of Cancer|March 1, 1992
Study of the biological and prognostic significance of the antigen CaMBr8 on breast carcinomaP Facheris, F Perrone, S Ménard, et al.
Cancer Immunology, Immunotherapy : CII|July 1, 1997
Efficiency of T cell triggering by anti-CD3 monoclonal antibodies (mAb) with potential usefulness in bispecific mAb generationN Jacobs, A Mazzoni, D Mezzanzanica, et al.
Cancer Research|October 10, 1998
Selective localization of matrix metalloproteinase 9, beta1 integrins, and human lymphocyte antigen class I molecules on membrane vesicles shed by 8701-BC breast carcinoma cellsV Dolo, A Ginestra, D Cassarà, et al.
Pageof 14